BlackRock Investment Management’s Evolent Health EVH Stock Holding History

BlackRock Investment Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1M	Buy	67,732 +4,069	+6%	+$80.2K	﹤0.01%	2693
2016 Q3	$1.57M	Sell	63,663 -296	-0.5%	-$6.92K	﹤0.01%	2358
2016 Q2	$1.23M	Buy	63,959 +16,405	+34%	+$225K	﹤0.01%	2480
2016 Q1	$502K	Buy	47,554 +2,437	+5%	+$25.2K	﹤0.01%	2903
2015 Q4	$546K	Buy	45,117 +1,123	+3%	+$16.5K	﹤0.01%	2971
2015 Q3	$702K	Buy	43,994 +1,694	+4%	+$33K	﹤0.01%	2861
2015 Q2	$825K	Buy	+42,300	New	+$789K	﹤0.01%	2908

Other funds holding EVH

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

BlackRock Investment Management's EVH Position: Q4 2016 in Review

BlackRock Investment Management increased its Evolent Health (EVH) stake by 6.4% in Q4 2016, buying an estimated $80.2K and bringing the position to 67,732 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

BlackRock Investment Management first reported a position in EVH in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.57M in Q3 2016. 118 funds tracked by Wall St. Rank hold EVH as of Q4 2016.

BlackRock Investment Management held 67,732 shares of Evolent Health worth $1M as of Q4 2016.
BlackRock Investment Management bought 4,069 Evolent Health shares in Q4 2016, an estimated $80.2K.
Evolent Health made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2693 holding.
BlackRock Investment Management first reported a position in Evolent Health in Q2 2015 and has held it in 7 quarters since.
BlackRock Investment Management's Evolent Health position peaked at $1.57M in Q3 2016.
118 funds tracked by Wall St. Rank held Evolent Health as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.